Sustained virological response after taking crushed elvitegravir-cobicistat-emtricitabine-tenofovir tablets.
Division of Infectious Diseases.
Patricia Pecora
PP
Fulco
Veronica A
VA
Ayala-Sims
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D002219:Carbamates / Q000008:administration & dosage*; D000069547:Cobicistat; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000068679:Emtricitabine; D005260:Female; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D063065:Organophosphonates / Q000008:administration & dosage*; D011208:Powders; D015363:Quinolones / Q000008:administration & dosage*; D013607:Tablets; D000068698:Tenofovir; D013844:Thiazoles / Q000008:administration & dosage*; D019562:Viral Load
D002219:Carbamates; D063065:Organophosphonates; D011208:Powders; D015363:Quinolones; D013607:Tablets; D013844:Thiazoles; D003841:Deoxycytidine; C509700:elvitegravir; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine; D000069547:Cobicistat